Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Cardiac-resynchronization therapy for the prevention of heart-failure events.

Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes NA 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W; MADIT-CRT Trial Investigators.

N Engl J Med. 2009 Oct 1;361(14):1329-38. doi: 10.1056/NEJMoa0906431. Epub 2009 Sep 1.

2.

Movement of the esophagus during left atrial catheter ablation for atrial fibrillation.

Good E, Oral H, Lemola K, Han J, Tamirisa K, Igic P, Elmouchi D, Tschopp D, Reich S, Chugh A, Bogun F, Pelosi F Jr, Morady F.

J Am Coll Cardiol. 2005 Dec 6;46(11):2107-10. Epub 2005 Nov 9.

3.

Effect of left atrial circumferential ablation for atrial fibrillation on left atrial transport function.

Lemola K, Desjardins B, Sneider M, Case I, Chugh A, Good E, Han J, Tamirisa K, Tsemo A, Reich S, Tschopp D, Igic P, Elmouchi D, Bogun F, Pelosi F Jr, Kazerooni E, Morady F, Oral H.

Heart Rhythm. 2005 Sep;2(9):923-8.

PMID:
16171744
4.

Pulmonary vein isolation as an end point for left atrial circumferential ablation of atrial fibrillation.

Lemola K, Oral H, Chugh A, Hall B, Cheung P, Han J, Tamirisa K, Good E, Bogun F, Pelosi F Jr, Morady F.

J Am Coll Cardiol. 2005 Sep 20;46(6):1060-6.

5.

Topographic analysis of the coronary sinus and major cardiac veins by computed tomography.

Lemola K, Mueller G, Desjardins B, Sneider M, Case I, Good E, Han J, Tamirisa K, Tschopp D, Reich S, Igic P, Elmouchi D, Chugh A, Bogun F, Pelosi F Jr, Kazerooni EA, Morady F, Oral H.

Heart Rhythm. 2005 Jul;2(7):694-9.

PMID:
15992723
6.

Mechanical interruption of postinfarction ventricular tachycardia as a guide for catheter ablation.

Bogun F, Good E, Han J, Tamirisa K, Reich S, Elmouchi D, Igic P, Lemola K, Oral H, Chugh A, Pelosi F, Morady F.

Heart Rhythm. 2005 Jul;2(7):687-91.

PMID:
15992721
7.

Catheter ablation of atypical atrial flutter and atrial tachycardia within the coronary sinus after left atrial ablation for atrial fibrillation.

Chugh A, Oral H, Good E, Han J, Tamirisa K, Lemola K, Elmouchi D, Tschopp D, Reich S, Igic P, Bogun F, Pelosi F Jr, Morady F.

J Am Coll Cardiol. 2005 Jul 5;46(1):83-91.

8.

Effects of left atrial ablation of atrial fibrillation on size of the left atrium and pulmonary veins.

Lemola K, Sneider M, Desjardins B, Case I, Chugh A, Hall B, Cheung P, Good E, Han J, Tamirisa K, Bogun F, Pelosi F Jr, Kazerooni E, Morady F, Oral H.

Heart Rhythm. 2004 Nov;1(5):576-81.

PMID:
15851222
9.

Mechanisms of recurrent atrial fibrillation after pulmonary vein isolation by segmental ostial ablation.

Lemola K, Hall B, Cheung P, Good E, Han J, Tamirisa K, Chugh A, Bogun F, Pelosi F Jr, Morady F, Oral H.

Heart Rhythm. 2004 Jul;1(2):197-202.

PMID:
15851153
10.

Prevalence, mechanisms, and clinical significance of macroreentrant atrial tachycardia during and following left atrial ablation for atrial fibrillation.

Chugh A, Oral H, Lemola K, Hall B, Cheung P, Good E, Tamirisa K, Han J, Bogun F, Pelosi F Jr, Morady F.

Heart Rhythm. 2005 May;2(5):464-71.

PMID:
15840468
11.

Spironolactone-induced renal insufficiency and hyperkalemia in patients with heart failure.

Tamirisa KP, Aaronson KD, Koelling TM.

Am Heart J. 2004 Dec;148(6):971-8.

PMID:
15632880
12.

Computed tomographic analysis of the anatomy of the left atrium and the esophagus: implications for left atrial catheter ablation.

Lemola K, Sneider M, Desjardins B, Case I, Han J, Good E, Tamirisa K, Tsemo A, Chugh A, Bogun F, Pelosi F Jr, Kazerooni E, Morady F, Oral H.

Circulation. 2004 Dec 14;110(24):3655-60. Epub 2004 Nov 29.

13.

Noninducibility of atrial fibrillation as an end point of left atrial circumferential ablation for paroxysmal atrial fibrillation: a randomized study.

Oral H, Chugh A, Lemola K, Cheung P, Hall B, Good E, Han J, Tamirisa K, Bogun F, Pelosi F Jr, Morady F.

Circulation. 2004 Nov 2;110(18):2797-801. Epub 2004 Oct 25.

14.

Prevalence of asymptomatic recurrences of atrial fibrillation after successful radiofrequency catheter ablation.

Oral H, Veerareddy S, Good E, Hall B, Cheung P, Tamirisa K, Han J, Fortino J, Chugh A, Bogun F, Pelosi F Jr, Morady F.

J Cardiovasc Electrophysiol. 2004 Aug;15(8):920-4.

15.

Detection of inadvertent catheter movement into a pulmonary vein during radiofrequency catheter ablation by real-time impedance monitoring.

Cheung P, Hall B, Chugh A, Good E, Lemola K, Han J, Tamirisa K, Pelosi F Jr, Morady F, Oral H.

J Cardiovasc Electrophysiol. 2004 Jun;15(6):674-8.

16.

Ventricular tachycardia associated with transmyocardial migration of an epicardial pacing wire.

Meier DJ, Tamirisa KP, Eitzman DT.

Ann Thorac Surg. 2004 Mar;77(3):1077-9.

PMID:
14992934
17.

Gene therapy in cardiovascular diseases.

Tamirisa KP, Mukherjee D.

Curr Gene Ther. 2002 Dec;2(4):427-35. Review.

PMID:
12477254
18.

For left ventricular opacification and endocardial border definition: is it really important which contrast agent we use, or is it the imaging modality we choose?

Dolan MS, El-Shafei A, Puri S, Tamirisa K, St Vrain J, Flanagan J, Havens E, Labovitz AJ.

Eur J Echocardiogr. 2001 Sep;2(3):154-62.

PMID:
11882448
19.

Effect of intravenous contrast for left ventricular opacification and border definition on sensitivity and specificity of dobutamine stress echocardiography compared with coronary angiography in technically difficult patients.

Dolan MS, Riad K, El-Shafei A, Puri S, Tamirisa K, Bierig M, St Vrain J, McKinney L, Havens E, Habermehl K, Pyatt L, Kern M, Labovitz AJ.

Am Heart J. 2001 Nov;142(5):908-15.

PMID:
11685180
20.

Tissue factor pathway inhibitor attenuates procoagulant activity and upregulation of tissue factor at the site of balloon-induced arterial injury in pigs.

St Pierre J, Yang LY, Tamirisa K, Scherrer D, De Ciechi P, Eisenberg P, Tolunay E, Abendschein D.

Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2263-8.

Supplemental Content

Loading ...
Support Center